DE202169C - - Google Patents

Info

Publication number
DE202169C
DE202169C DENDAT202169D DE202169DA DE202169C DE 202169 C DE202169 C DE 202169C DE NDAT202169 D DENDAT202169 D DE NDAT202169D DE 202169D A DE202169D A DE 202169DA DE 202169 C DE202169 C DE 202169C
Authority
DE
Germany
Prior art keywords
hydrochloric acid
dioxyphenylethanolmethylamine
absolute alcohol
alcoholic
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT202169D
Other languages
German (de)
Publication of DE202169C publication Critical patent/DE202169C/de
Active legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

KAISERLICHESIMPERIAL

PATENTAMT.PATENT OFFICE.

Alle Versuche, kristallisierte Salze des als »Suprarenin« oder »Adrenalin« im Handel befindlichen o-Dioxyphenyläthanolmethylamin .zu gewinnen, waren seither erfolglos (vgl. u. a. 5 J. Takamine, Chemisches Centralblatt 1901, II, S. 1354). Die Base selbst ist unlöslich; sie wurde daher in salzsaurer Lösung in Handel gebracht. Diese Lösung hatte indes den Nach-' teil, daß sie schlecht haltbar war und nur unter Zusatz von Konservierungsmitteln verwendet werden konnte. Ein vollkommen luftbeständiges, kristallisierendes, in Wasser leicht und neutral lösliches Salz des o-Dioxyphenyläthanolmethylamins wäre therapeutisch von bedeutendem Wert.All attempts to find crystallized salts of what is commercially available as "Suprarenin" or "Adrenalin" o-Dioxyphenylethanolmethylamine. to win have since then been unsuccessful (cf. 5 J. Takamine, Chemisches Centralblatt 1901, II, p. 1354). The base itself is insoluble; it was therefore marketed in a hydrochloric acid solution. This solution, however, had the disadvantage ' part of the fact that it was poorly preserved and only used with the addition of preservatives could be. A completely air-resistant, crystallizing one, easily in water and neutrally soluble salt of o-dioxyphenylethanolmethylamine would be of significant therapeutic value.

Es wurde nun gefunden, daß man das salzsaure Salz der Base in schönen Kristallen und in guter Ausbeute erhält, wenn man synthetisch dargestelltes o-Dioxyphenyläthanolmethylamin (vgl. Patent 157300, Kl. 12 q, Beispiel 1) mit alkoholischer Salzsäure behandelt. It has now been found that the hydrochloric acid salt of the base can be converted into beautiful crystals and obtained in good yield if synthetically prepared o-dioxyphenylethanolmethylamine is used (cf. Patent 157300, class 12 q, example 1) treated with alcoholic hydrochloric acid.

Beispiel: iMolekül synthetisch dargestelltes o-Dioxyphenyläthanolmethylamin wird mit etwas absolutem Alkohol durchfeuchtet und in der theoretisch nötigen Menge alkoholischer Salzsäure gelöst. Nach einiger Zeit, namentlich nach häufigem Rühren mit dem Glasstab kristallisiert die Flüssigkeit. Die Kristalle werden abgesaugt, mit absolutem Alkohol und Äther gewaschen und aus Alkohol umkristallisiert.Example: i molecule of synthetically produced o-dioxyphenylethanolmethylamine is moistened with a little absolute alcohol and dissolved in the theoretically necessary amount of alcoholic hydrochloric acid. After a while, namely after frequent stirring with the glass rod, the liquid crystallizes. The crystals are filtered off with suction, washed with absolute alcohol and ether and recrystallized from alcohol.

Das auf diese Weise erhaltene salzsaure o-Dioxyphenyläthanolmethylamin ist farblos, leicht und mit neutraler Reaktion in Wasser löslich, schwer löslich in absolutem Alkohol. Es schmilzt bei 1570.The hydrochloric acid o-dioxyphenylethanolmethylamine obtained in this way is colorless, easily and with a neutral reaction soluble in water, sparingly soluble in absolute alcohol. It melts at 157 0 .

3535

Claims (1)

Patent-Anspruch:Patent claim: Verfahren zur Darstellung des salzsauren Salzes von o-Dioxyphenyläthanolmethylamin in kristallisierter Form, dadurch gekennzeichnet, daß man die synthetisch gewonnene Base mit alkoholischer Salzsäure behandelt' und auskristallisieren läßt.Process for the preparation of the hydrochloric acid salt of o-dioxyphenylethanolmethylamine in crystallized form, characterized in that the synthetically obtained Base treated with alcoholic hydrochloric acid and allowed to crystallize.
DENDAT202169D Active DE202169C (en)

Publications (1)

Publication Number Publication Date
DE202169C true DE202169C (en)

Family

ID=464673

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT202169D Active DE202169C (en)

Country Status (1)

Country Link
DE (1) DE202169C (en)

Similar Documents

Publication Publication Date Title
DE2422737B2 (en) METHOD OF PREPARING THE D-AMINO ACIDS D - (-) - VALIN AND D - (-) - ALANINE
DE202169C (en)
DE2256215C3 (en) Insulin preparation containing crystalline insulin and amorphous desphenylalanine8 '-insulin
DE220355C (en)
DE98031C (en)
DE165898C (en)
DE633786C (en) Process for the preparation of complex compounds of 1,3-dimethylxanthine
DE613125C (en) Process for the preparation of water-soluble compounds of the oxydiphenyl ethers and their substitution products
DE213155C (en)
DE657106C (en) Process for the preparation of N-methyl-C, C-allylisopropylbarbituric acid
CH374644A (en) Process for the preparation of optically active α-ethyl-phenylacetylurea
DE234631C (en)
DE576712C (en) Process for the preparation of a double salt of ª ‰ -Bromaethyltrimethylammonium
AT203000B (en) Process for the preparation of new salts of 4,6-dioxyisophthalic acid and 5-halogen (especially 5-iodine) - 4,6-dioxyisophthalic acid
DE524639C (en) Process for the preparation of easily soluble salts of benzylmorphone
DE158620C (en)
DE116806C (en)
DE712791C (en) Process for the preparation of solutions of the blood sugar lowering pancreatic hormone
AT143480B (en) Process for the preparation of a quinine compound.
DE965405C (en) Process for the production of drugs with an oxytocic and sympatholytic effect by reacting the diaethylamide of diaethylamino-acetic acid with physiologically compatible acids
DE629841C (en) Process for the preparation of an aqueous quinine solution for injection purposes
AT201234B (en) Process for the production of insulin crystals of approximately uniform size
DE855614C (en) Process for the preparation of penicillin solutions with long-lasting effects
DE528584C (en) Process for the production of organic arsenic compounds
DE239311C (en)